PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
129 hedge funds and large institutions have $222M invested in Progenics Pharmaceuticals Inc in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 46
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
129
Holding in Top 10
–
Calls
$408K
Puts
$145K
Top Buyers
| 1 | +$4.18M | |
| 2 | +$3.14M | |
| 3 | +$3.03M | |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$2.71M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.56M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$20.1M | |
| 3 | -$3.07M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.74M |
| 5 |
BlackRock
New York
|
-$1.67M |